DUBLIN--(BUSINESS WIRE)--The "Japan Market Report for Coronary Stents 2018 - MedCore" report has been added to ResearchAndMarkets.com's offering.
Angioplasty procedures are performed only after a problem has been detected by a diagnostic procedure, such as X-ray based angiography. In addition to stents, angioplasty procedures utilize a number of accessory products including introducer sheaths, PTCA balloon catheters, interventional catheters and guidewires, diagnostic catheters and guidewires, atherectomy devices, chronic total occlusion (CTO) devices, vascular closure devices (VCD), intravascular ultrasound (IVUS) catheters and optical coherence tomography (OCT) catheters.
As of 2017, there are three main types of stents used for coronary applications: bare-metal, drug-eluting and bioabsorbable stents. Bare-metal stents (BMS) consist of a wire mesh that is designed to expand and keep the lumen from closing again. BMS were introduced in 1994 by Johnson & Johnson and within a few years, millions of these devices were being placed worldwide. Because minimally invasive procedures such as angioplasties are faster, easier to perform, safer and less expensive than CABG procedures, far more patients could be treated than prior to stent introduction. After a few years of use, it was found that bare-metal stents, while effective at dilating arteries, were associated with a substantial risk of restenosis, where the arterial wall would heal over the stent and occlude the artery again.
Restenosis requires an additional stenting or CABG procedure to be performed, dramatically increasing costs as well as the risk to the patient. To counter the risk of restenosis, drug-eluting stents (DES) were developed. These stents are coated with a polymer containing a drug that inhibits healing and reduces the rate of restenosis.
Key Topics Covered:
1. Research Methodology
2. Disease Overview
2.1 Basic Anatomy
2.2 Disease Treatments And Diagnostics
2.3 Patient Demographics
3. Product Assessment
3.1 Product Portfolios
3.2 Regulatory Issues And Recalls
3.3 Clinical Trials
4. Coronary Stent Market
4.2 Market Overview
4.3 Market Analysis And Forecast
4.4 Drivers And Limiters
4.5 Competitive Market Share Analysis
- Boston Scientific
- Philips Volcano
- Goodman Co.
- Cardinal Health
- B. Braun
- Biosensors International Group Ltd.
- C.R. Bard
- Cardiovascular Systems Inc.
- Cook Medical
- Merit Medical
- Straub Medical
- W. L. Gore
For more information about this report visit https://www.researchandmarkets.com/research/zbgrqj/japan_market?w=4
Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.